RecruitingNAINTERVENTIONAL

Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island.

This study aims to understand why some people with pre-diabetes on Reunion Island develop type 2 diabetes. Diabetes is a major health issue there, affecting many people and leading to serious health complications like heart attacks and strokes. The number of new diabetes cases is rising quickly. Currently, 10% of the population has treated diabetes, the highest rate in France. Researchers want to identify what makes people more or less likely to get diabetes, focusing on those already showing early signs (prediabetes). This information could help create better prevention programs tailored to the unique community on Reunion Island.

At a glance

Status

Recruiting

Phase

Sponsor

Centre Hospitalier Universitaire de la Réunion

Enrolment target

2,000

Start

18 Jul 2019

Estimated completion

01 Dec 2026

Diabetes

What is this study about?

This study is focused on understanding diabetes on Reunion Island, a place where this condition is a really big health concern. Doctors and researchers have noticed that diabetes affects a lot of people there – more than anywhere else in France – and it often leads to serious health problems like heart disease and strokes. Sadly, people on Reunion Island are also more likely to die from diabetes, especially if they are under 65. Even though there are already programs to find and prevent diabetes, the number of people getting it keeps going up.

The researchers have also found some interesting differences in people with diabetes on Reunion Island compared to other places. For example, more women are affected, and they tend to be thinner and get diabetes at a younger age. These unique patterns mean that we need to better understand why diabetes is spreading so quickly there and what factors play a role.

At the heart of this study is something called 'prediabetes'. This is when your blood sugar levels are higher than normal but not high enough to be called full-blown diabetes. It's like a warning sign. Many people with prediabetes are at a very high risk of developing diabetes – up to 70% of them could get it. By studying people with prediabetes, the researchers hope to find out what things (like lifestyle, genes, or other health conditions) either protect people from getting diabetes or make them more likely to get it. This knowledge is key to developing better ways to prevent diabetes and help people stay healthier on Reunion Island.

Key takeaways

Diabetes is a major health problem on Reunion Island, with high rates and serious complications.
The study wants to understand the unique challenges of diabetes on Reunion Island.
It focuses on 'prediabetes' – when blood sugar is high but not yet full diabetes.
Researchers aim to find out what helps or harms people with prediabetes.
The information gained could lead to better diabetes prevention strategies specific to Reunion Island.

Who may be eligible?

To join this study, you need to be between 25 and 70 years old. You must also have 'prediabetes', which means your recent blood tests (done in the last 3 months) showed your blood sugar was a bit higher than normal, but you haven't been diagnosed with diabetes before.

You also need to be a patient of one of the doctors involved in the study and be able to answer questions over the phone. Importantly, you shouldn't have been diagnosed or treated for diabetes, unless it was for gestational diabetes (diabetes during pregnancy) in the past.

You can't take part if you plan to move away from Reunion Island within the next two years, are currently pregnant, or are already involved in another research study. Also, if you have severe physical or mental health problems that might make it hard to follow the study's instructions, you might not be able to participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 25 and 70 years old?
Do you have prediabetes (high blood sugar, but not full diabetes)?
Have you never been diagnosed with or treated for diabetes (except gestational diabetes)?
Are you a patient of one of the general practitioners involved in the study?
Do you plan to stay on Reunion Island for at least the next two years?

Answer every question to see your result.

What does participation involve?

The details of participating in this study specifically mention answering a telephone survey questionnaire. It does not go into detail about visits, other assessments, or medication. The study focuses on understanding factors, so it is likely observational, meaning researchers will gather information from you without giving new treatments. The overall duration is not mentioned, but participants should not plan to leave Reunion Island within 2 years, suggesting a study length of at least that long.

Potential risks and benefits

A potential benefit of taking part in this study is contributing to a better understanding of diabetes and its prevention on Reunion Island, which could help many people in the future. As this appears to be an observational study focusing on surveys, there are likely minimal direct risks beyond the time commitment for the survey. You have the right to withdraw from the study at any time without giving a reason, and this will not affect your routine medical care.

Locations (1)

Centre Hospitalier Universitaire de la Réunion
Verified postcode
Saint-Pierre, France· Recruiting

Common questions

What is prediabetes?

Prediabetes means your blood sugar levels are higher than normal, but not yet high enough to be called type 2 diabetes. It's a warning sign that you're at increased risk of developing diabetes.

What is the goal of this study?

The study aims to find out why some people with prediabetes go on to develop type 2 diabetes, especially on Reunion Island, to help create better prevention methods.

Who is this study for?

This study is for adults aged 25 to 70 living on Reunion Island who have been recently diagnosed with prediabetes and meet other specific criteria.

Will I have to take new medication?

The information provided suggests this study is about understanding factors, not testing new medications. It mentions a prevention program but doesn't specify if participants will receive new medications as part of the study.

How long will the study last?

The exact duration isn't stated, but participants shouldn't plan to leave Reunion Island within two years, suggesting the study could last at least that long.

How to find out more

Samir MEDJANE

samir.medjane@chu-reunion.fr 0262359750 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.